Indrayani Biotech Limited Stocks

8.68Last Updated 09.02.2026

Issuer Rating

4/7

Performance

Favourable

Risk

Considerable

Recommendation

Hold

Market Cap

₹ 4.13M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
8.68
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Indrayani Biotech Ltd. engages in business operations in the field of Food and Hospitality, Dairy, Healthcare and Pharma, Engineering, Biotech, Agriculture, and Infrastructure. It operates through the following segments: Foods and Hospitality, Engineering, and Healthcare. The company was founded on March 9, 1992 and is headquartered in Chennai, India.

Company Valuation

Greatly undervalued
7/7

From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks. Specifically, the stock is undervalued on EV/EBITDA.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks